DK166259C - ORAL TABLE FOR PH INDEPENDENT RELEASE - Google Patents

ORAL TABLE FOR PH INDEPENDENT RELEASE

Info

Publication number
DK166259C
DK166259C DK181084A DK181084A DK166259C DK 166259 C DK166259 C DK 166259C DK 181084 A DK181084 A DK 181084A DK 181084 A DK181084 A DK 181084A DK 166259 C DK166259 C DK 166259C
Authority
DK
Denmark
Prior art keywords
dipyridamole
acid
independent release
independent
oral table
Prior art date
Application number
DK181084A
Other languages
Danish (da)
Other versions
DK181084D0 (en
DK181084A (en
DK166259B (en
Inventor
Jung-Yong Park
Jerzy Debski
Kieran G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of DK181084D0 publication Critical patent/DK181084D0/en
Publication of DK181084A publication Critical patent/DK181084A/en
Publication of DK166259B publication Critical patent/DK166259B/en
Application granted granted Critical
Publication of DK166259C publication Critical patent/DK166259C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Novel pH independent, controlled release oral tablets comprising an effective amount of an intimate mixture of dipyridamole or an acid addition salt thereof, at least 18 acid equivalents of at least one non-toxic, pharmaceutical acid or acid substance per mole of dipyridamole and a sufficient amount of a disintegration agent to allow at least 90% dissolution of dipyridamole in the gastrointestinal pH range of 1 to 7.
DK181084A 1983-04-08 1984-04-06 ORAL TABLE FOR PH INDEPENDENT RELEASE DK166259C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08
US48328583 1983-04-08

Publications (4)

Publication Number Publication Date
DK181084D0 DK181084D0 (en) 1984-04-06
DK181084A DK181084A (en) 1984-10-09
DK166259B DK166259B (en) 1993-03-29
DK166259C true DK166259C (en) 1993-08-23

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
DK181084A DK166259C (en) 1983-04-08 1984-04-06 ORAL TABLE FOR PH INDEPENDENT RELEASE

Country Status (20)

Country Link
EP (1) EP0121901B1 (en)
JP (1) JPS6034906A (en)
KR (1) KR880002139B1 (en)
AT (1) ATE32980T1 (en)
AU (1) AU570446B2 (en)
CA (1) CA1219216A (en)
DD (1) DD222496A5 (en)
DE (1) DE3469848D1 (en)
DK (1) DK166259C (en)
ES (1) ES531346A0 (en)
FI (1) FI82604C (en)
GR (1) GR81907B (en)
HU (1) HU191542B (en)
IE (1) IE57220B1 (en)
IL (1) IL71458A (en)
NO (1) NO164958C (en)
NZ (1) NZ207768A (en)
PH (1) PH21585A (en)
PT (1) PT78380B (en)
ZA (1) ZA842562B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (en) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 Matrice locks
JP2535141B2 (en) * 1995-01-17 1996-09-18 中外製薬株式会社 Fumaric acid-containing sustained-release preparation
DE10337697A1 (en) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablet containing 3 - [(2 - {[4- (hexyloxycarbonylamino-iminomethyl) -phenyl-amino] -methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] - propionic acid ethyl ester or its salts
BG860Y1 (en) * 2004-09-17 2007-02-28 "Софарма" Ад Medicamentous form of dipyridamol
JP2009504796A (en) * 2005-08-22 2009-02-05 ノバルティス アクチエンゲゼルシャフト PHARMACEUTICAL COMPOSITION COMPRISING A PH-DEPENDENT PHARMACEUTICAL COMPOUND, A PH ADJUSTING AGENT AND A RETARDANT
EP2101733B1 (en) 2006-12-13 2012-09-26 F. Hoffmann-La Roche AG Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
DD146547A5 (en) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim MEDICINAL RETARDANT SHAPE WITH UNFORGETTABLE POROESEN DIFFUSION SHELLS
DE3000979A1 (en) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach NEW DIPYRIDAMOL RETARD FORMS AND METHOD FOR THEIR PRODUCTION
DE3124090A1 (en) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach NEW ORAL DIPYRIDAMOL FORMS
JPS5839618A (en) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd Long-acting laminated tablet

Also Published As

Publication number Publication date
HUT34345A (en) 1985-03-28
NO841372L (en) 1984-10-09
FI82604C (en) 1991-04-10
JPS6034906A (en) 1985-02-22
IL71458A0 (en) 1984-07-31
IE840856L (en) 1984-10-08
GR81907B (en) 1984-12-12
EP0121901B1 (en) 1988-03-16
KR840008588A (en) 1984-12-17
PT78380B (en) 1986-08-14
FI841369A (en) 1984-10-09
PT78380A (en) 1984-05-01
DD222496A5 (en) 1985-05-22
DK181084D0 (en) 1984-04-06
NZ207768A (en) 1987-02-20
PH21585A (en) 1987-12-11
JPH0521892B2 (en) 1993-03-25
FI841369A0 (en) 1984-04-06
NO164958C (en) 1990-12-05
AU2660984A (en) 1984-10-11
EP0121901A1 (en) 1984-10-17
ES8601687A1 (en) 1985-11-01
DK181084A (en) 1984-10-09
DE3469848D1 (en) 1988-04-21
ES531346A0 (en) 1985-11-01
FI82604B (en) 1990-12-31
DK166259B (en) 1993-03-29
HU191542B (en) 1987-03-30
IE57220B1 (en) 1992-06-03
CA1219216A (en) 1987-03-17
KR880002139B1 (en) 1988-10-17
IL71458A (en) 1987-09-16
ZA842562B (en) 1985-12-24
NO164958B (en) 1990-08-27
ATE32980T1 (en) 1988-04-15
AU570446B2 (en) 1988-03-17

Similar Documents

Publication Publication Date Title
MA23170A1 (en) PROCESS FOR THE PREPARATION OF A NEW COMPOUND.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
TNSN95076A1 (en) DOSAGE FORM II OF MULTIPLE TABLET UNIT
DE69212882T2 (en) Stomach-stable pharmaceutical composition containing bile acid salts for oral administration
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
FI895342A0 (en) Ibuprofen-BRUSPRODUKTER.
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
DE19975062I1 (en) Pharmaceutical compositions containing N-substituted 3-hydroxypyrid-2-one or 4-one derivatives
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
ATE158504T1 (en) EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS
GB2192131B (en) Pharmaceutical compositions containing calcium salts.
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
DK166259C (en) ORAL TABLE FOR PH INDEPENDENT RELEASE
DK209384D0 (en) 4-PHENYL-TETRAHYDRO-FURANO-PYRIDINES AND ACID ADDITION SALTS, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS
ATE15331T1 (en) PROCESSES FOR THE ORAL ADMINISTRATION OF SUBSTANCES IN THE FORM OF LIPOSOMES, AND THEIR PHARMACEUTICAL COMPOSITIONS.
GB2051796B (en) (3 - alkylamino - 2 - hydroxypropoxy)-furan - 2 - carboxylic acid anilides and physiologically tolerated acid addition salts thereof processes for their preparation and medicaments containing them
ATE45090T1 (en) PHARMACEUTICAL COMPOSITION IN ORAL DOSAGE FORM.
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
BE862305A (en) 2-BROMO-3-CHLORO-N-2-IMIDAZOLIDINYLIDENE-BENZAMINE, ITS ADDITIONAL SALTS WITH ACIDS, MEDICINAL PRODUCTS CONTAINING IT AND METHODS FOR ITS PREPARATION

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK